RAP 0.00% 20.5¢ raptor resources limited

Ann: FDA Consultant Engagement, page-25

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. 6,615 Posts.
    lightbulb Created with Sketch. 1
    Totally agree. Sub IPO price and current market cap are a gift at these levels.

    I'm confident in the app working and the initial test results.

    This is based on what i've read, researched and the team behind this.

    also, Experien Group (partners helping secure FDA approval) don't seem like the type of company to go out on a limb for just anyone. 99% track record highlights this.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.